Protease inhibitors in HIV infection - Lipodystrophy may be a consequence of prolonged survival

被引：11
作者：
Buss, N [1 ]
Duff, F
机构：
[1] F Hoffmann La Roche & Co Ltd, CH-1070 Basel, Switzerland
[2] Roche Biomed Labs, Nutley, NJ USA
来源：
BRITISH MEDICAL JOURNAL | 1999年 / 318卷 / 7176期
关键词：
D O I：
10.1136/bmj.318.7176.122
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：122 / 122
页数：1
相关论文
共 5 条
[1]   Protease inhibitors may cause fat abnormalities and heart disease [J].
Berger, A .
BRITISH MEDICAL JOURNAL, 1998, 317 (7151) :100-100
[2]   A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors [J].
Carr, A ;
Samaras, K ;
Burton, S ;
Law, M ;
Freund, J ;
Chisholm, DJ ;
Cooper, DA .
AIDS, 1998, 12 (07) :F51-F58
[3]   Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance [J].
Carr, A ;
Samaras, K ;
Chisholm, DJ ;
Cooper, DA .
LANCET, 1998, 351 (9119) :1881-1883
[4]  
KOTLER DP, 1998, 12 WORLD AIDS C 28 J
[5]   Buffalo hump in men with HIV-1 infection [J].
Lo, JC ;
Mulligan, K ;
Tai, VW ;
Algren, H ;
Schambelan, M .
LANCET, 1998, 351 (9106) :867-870
1